Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Hepatitis C

  Free Subscription


Articles published in J Virol

Retrieve available abstracts of 103 articles:
HTML format
Text format



Single Articles


    October 2019
  1. WU MJ, Shanmugam S, Welsch C, Yi M, et al
    Palmitoylation of the hepatitis C virus NS2 regulates its subcellular localization and NS2-NS3 autocleavage.
    J Virol. 2019 Oct 9. pii: JVI.00906-19. doi: 10.1128/JVI.00906.
    PubMed     Text format     Abstract available


    September 2019
  2. VAZQUEZ C, Tan CY, Horner SM
    Hepatitis C virus infection is inhibited by a non-canonical antiviral signaling pathway targeted by NS3-NS4A.
    J Virol. 2019 Sep 18. pii: JVI.00725-19. doi: 10.1128/JVI.00725.
    PubMed     Text format     Abstract available


  3. TSAI CN, Pan TC, Chiang CH, Yu CC, et al
    Serine 229 balances the hepatitis C virus nonstructural protein NS5A between hypo- and hyper-phosphorylated states.
    J Virol. 2019 Sep 11. pii: JVI.01028-19. doi: 10.1128/JVI.01028.
    PubMed     Text format     Abstract available


  4. WANG H, Tai AW
    Nir2 is an effector of VAPs necessary for efficient HCV replication and PI(4)P enrichment at the viral replication organelle.
    J Virol. 2019 Sep 4. pii: JVI.00742-19. doi: 10.1128/JVI.00742.
    PubMed     Text format     Abstract available


    August 2019
  5. JOHNSON J, Freedman H, Logan M, Wong JAJ, et al
    A recombinant HCV genotype 1a E1/E2 envelope glycoprotein vaccine elicits antibodies that differentially neutralize closely related 2a strains through interactions of the N-terminal hypervariable region 1 of E2 with scavenger receptor B1.
    J Virol. 2019 Aug 28. pii: JVI.00810-19. doi: 10.1128/JVI.00810.
    PubMed     Text format     Abstract available


  6. CHEN TI, Hsu YK, Chou CY, Chen YH, et al
    Hepatitis C Virus NS3 Protein Plays a Dual Role in WRN-Mediated Repair of Non-Homologous End Joining.
    J Virol. 2019 Aug 28. pii: JVI.01273-19. doi: 10.1128/JVI.01273.
    PubMed     Text format     Abstract available


  7. SHWETHA S, Kumar A, Mullick R, Vasudevan D, et al
    Correction for Shwetha et al., "HuR Displaces Polypyrimidine Tract Binding Protein To Facilitate La Binding to the 3' Untranslated Region and Enhances Hepatitis C Virus Replication".
    J Virol. 2019;93.
    PubMed     Text format    


    July 2019
  8. SCHULT P, Nattermann M, Lauber C, Seitz S, et al
    Evidence for internal initiation of RNA synthesis by the Hepatitis C virus RNA-dependent RNA polymerase NS5B in cellulo.
    J Virol. 2019 Jul 17. pii: JVI.00525-19. doi: 10.1128/JVI.00525.
    PubMed     Text format     Abstract available


  9. MEKONNEN ZA, Grubor-Bauk B, English K, Leung P, et al
    Single dose vaccination with a hepatotropic Adeno-associated virus (AAV) efficiently localises T cell immunity in the liver with the potential to confer rapid protection against hepatitis C virus (HCV).
    J Virol. 2019 Jul 10. pii: JVI.00202-19. doi: 10.1128/JVI.00202.
    PubMed     Text format     Abstract available


  10. WOLFISBERG R, Holmbeck K, Nielsen L, Kapoor A, et al
    Replicons of a rodent hepatitis C model virus permit selection of highly permissive cells.
    J Virol. 2019 Jul 10. pii: JVI.00733-19. doi: 10.1128/JVI.00733.
    PubMed     Text format     Abstract available


    June 2019
  11. PATRA T, Sasaki R, Meyer K, Ray RB, et al
    TGF-beta acts as a regulatory molecule for lipogenic pathway among hepatitis C virus genotype specific infection.
    J Virol. 2019 Jun 26. pii: JVI.00811-19. doi: 10.1128/JVI.00811.
    PubMed     Text format     Abstract available


    May 2019
  12. COLBERT MD, Flyak AI, Ogega CO, Kinchen VJ, et al
    Broadly neutralizing antibodies targeting new sites of vulnerability in hepatitis C virus E1E2.
    J Virol. 2019 May 8. pii: JVI.02070-18. doi: 10.1128/JVI.02070.
    PubMed     Text format     Abstract available


  13. QIN Y, Xun Z, Guo Y, Chen S, et al
    Sam68 Promotes Hepatitis C Virus Replication by Interaction with Stem-Loop 2 of Viral 5' Untranslated Region.
    J Virol. 2019 May 8. pii: JVI.00693-19. doi: 10.1128/JVI.00693.
    PubMed     Text format     Abstract available


    March 2019
  14. SAHUC ME, Sahli R, Riviere C, Pene V, et al
    Dehydrojuncusol, a Natural Phenanthrene Compound Extracted from Juncus maritimus Is a New Inhibitor of Hepatitis C Virus RNA Replication.
    J Virol. 2019 Mar 6. pii: JVI.02009-18. doi: 10.1128/JVI.02009.
    PubMed     Text format     Abstract available


    February 2019
  15. BANG BR, Li M, Tsai KN, Aoyagi H, et al
    Regulation of HCV infection by Cellular Retinoic Acid Binding Proteins through the modulation of lipid droplet abundance.
    J Virol. 2019 Feb 6. pii: JVI.02302-18. doi: 10.1128/JVI.02302.
    PubMed     Text format     Abstract available


    January 2019
  16. MARIN MQ, Perez P, Ljungberg K, Sorzano COS, et al
    Potent Anti-Hepatitis C (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-launched RNA Replicons and MVA-HCV.
    J Virol. 2019 Jan 23. pii: JVI.00055-19. doi: 10.1128/JVI.00055.
    PubMed     Text format     Abstract available


  17. URBANOWICZ RA, Wang R, Schiel JE, Keck ZY, et al
    Antigenicity and Immunogenicity of Differentially Glycosylated HCV E2 Envelope Proteins Expressed in Mammalian and Insect Cells.
    J Virol. 2019 Jan 16. pii: JVI.01403-18. doi: 10.1128/JVI.01403.
    PubMed     Text format     Abstract available


  18. KUSAKABE S, Suzuki T, Sugiyama Y, Haga S, et al
    USP15 participates in HCV propagation through the regulation of viral RNA translation and lipid droplet formation.
    J Virol. 2019 Jan 9. pii: JVI.01708-18. doi: 10.1128/JVI.01708.
    PubMed     Text format     Abstract available


    December 2018
  19. LEBSIR N, Goueslain L, Farhat R, Callens N, et al
    Functional and physical interaction between the Arf activator GBF1 and hepatitis C virus NS3 protein.
    J Virol. 2018 Dec 19. pii: JVI.01459-18. doi: 10.1128/JVI.01459.
    PubMed     Text format     Abstract available


    November 2018
  20. VELAZQUEZ-MOCTEZUMA R, Galli A, Law M, Bukh J, et al
    Hepatitis C virus escape studies for human antibody AR3A reveals a high barrier to resistance and novel insights on viral antibody evasion mechanisms.
    J Virol. 2018 Nov 28. pii: JVI.01909-18. doi: 10.1128/JVI.01909.
    PubMed     Text format     Abstract available


    October 2018
  21. PHAM HT, Nguyen TTT, Nguyen LP, Han SS, et al
    Hepatitis C virus downregulates ubiquitin conjugating enzyme E2S expression to prevent proteasomal degradation of NS5A, leading to host cells more sensitive to DNA damage.
    J Virol. 2018 Oct 31. pii: JVI.01240-18. doi: 10.1128/JVI.01240.
    PubMed     Text format     Abstract available


  22. YI DR, An N, Liu ZL, Xu FW, et al
    Human MxB inhibits the replication of HCV.
    J Virol. 2018 Oct 17. pii: JVI.01285-18. doi: 10.1128/JVI.01285.
    PubMed     Text format     Abstract available


    September 2018
  23. SCHENK C, Meyrath M, Warnken U, Schnolzer M, et al
    Characterization of a threonine-rich cluster in Hepatitis C virus nonstructural protein 5A and its contribution to hyperphosphorylation.
    J Virol. 2018 Sep 26. pii: JVI.00737-18. doi: 10.1128/JVI.00737.
    PubMed     Text format     Abstract available


  24. DOMINGUEZ-MOLINA B, Machmach K, Perales C, Tarancon-Diez L, et al
    Toll Like Receptor-7 and -9 agonists improve Hepatitis C Virus replication and infectivity inhibition by plasmacytoid dendritic cells.
    J Virol. 2018 Sep 19. pii: JVI.01219-18. doi: 10.1128/JVI.01219.
    PubMed     Text format     Abstract available


  25. HUANG H, Zhang C, Wang B, Wang F, et al
    Transduction with Lentiviral Vectors Altered the Expression Profile of Host MicroRNAs.
    J Virol. 2018;92.
    PubMed     Text format     Abstract available


  26. RAMSAY JD, Evanoff R, Mealey RH
    Hepacivirus A Infection in Horses Defines Distinct Envelope Hypervariable Regions and Elucidates Potential Roles of Viral Strain and Adaptive Immune Status in Determining Envelope Diversity and Infection Outcome.
    J Virol. 2018;92.
    PubMed     Text format     Abstract available


  27. BOEIJEN LL, Hou J, de Groen RA, Verbon A, et al
    Persistent replication of HIV, HCV and HBV results in distinct gene expression profiles by human NK cells.
    J Virol. 2018 Sep 5. pii: JVI.00575-18. doi: 10.1128/JVI.00575.
    PubMed     Text format     Abstract available


  28. XIE Q, Chen S, Tian R, Huang X, et al
    Long Noncoding RNA ITPRIP-1 Positively Regulates the Innate Immune Response through Promotion of Oligomerization and Activation of MDA5.
    J Virol. 2018;92.
    PubMed     Text format     Abstract available


    August 2018
  29. ZHAO Y, Cao X, Guo M, Wang X, et al
    NEURL3 is an inducible antiviral effector to inhibit HCV assembly by targeting viral E1 glycoprotein.
    J Virol. 2018 Aug 15. pii: JVI.01123-18. doi: 10.1128/JVI.01123.
    PubMed     Text format     Abstract available


  30. SUR S, Sasaki R, Devhare P, Steele R, et al
    Association between microRNA-373 and long non-coding RNA NORAD in hepatitis C virus infected hepatocytes impairs Wee1 expression for growth promotion.
    J Virol. 2018 Aug 8. pii: JVI.01215-18. doi: 10.1128/JVI.01215.
    PubMed     Text format     Abstract available


  31. HSU SC, Tsai CN, Lee KY, Pan TC, et al
    Sequential S232/S235/S238 Phosphorylation of the Hepatitis C Virus Nonstructural Protein 5A.
    J Virol. 2018 Aug 8. pii: JVI.01295-18. doi: 10.1128/JVI.01295.
    PubMed     Text format     Abstract available


  32. BARON AL, Schoeniger A, Becher P, Baechlein C, et al
    Mutational Analysis of the Bovine Hepacivirus Internal Ribosome Entry Site.
    J Virol. 2018;92.
    PubMed     Text format     Abstract available


  33. MOUSTAFA RI, Haddad JG, Linna L, Hanoulle X, et al
    Functional study of the C-terminal part of hepatitis C virus E1 ectodomain.
    J Virol. 2018 Aug 1. pii: JVI.00939-18. doi: 10.1128/JVI.00939.
    PubMed     Text format     Abstract available


    July 2018
  34. NYSTROM K, Wanrooij PH, Waldenstrom J, Adamek L, et al
    INOSINE TRIPHOSPHATE PYROPHOSPHATASE DEPHOSPHORYLATES RIBAVIRIN TRIPHOSPHATE AND REDUCED ENZYMATIC ACTIVITY POTENTIATES MUTAGENESIS IN HEPATITIS C VIRUS.
    J Virol. 2018 Jul 25. pii: JVI.01087-18. doi: 10.1128/JVI.01087.
    PubMed     Text format     Abstract available


    May 2018
  35. BELOUZARD S, Danneels A, Feneant L, Seron K, et al
    Correction for Belouzard et al., "Entry and Release of Hepatitis C Virus in Polarized Human Hepatocytes".
    J Virol. 2018;92.
    PubMed     Text format    


    April 2018
  36. KIM JY, Ou JJ
    Regulation of Apolipoprotein E Trafficking by Hepatitis C Virus-induced Autophagy.
    J Virol. 2018 Apr 25. pii: JVI.00211-18. doi: 10.1128/JVI.00211.
    PubMed     Text format     Abstract available


  37. MATSUI C, Deng L, Minami N, Abe T, et al
    Hepatitis C virus NS5A protein promotes the lysosomal degradation of hepatocyte nuclear factor 1alpha via chaperone-mediated autophagy.
    J Virol. 2018 Apr 25. pii: JVI.00639-18. doi: 10.1128/JVI.00639.
    PubMed     Text format     Abstract available


  38. IQBAL J, Sarkar-Dutta M, McRae S, Ramachandran A, et al
    Osteopontin regulates HCV replication and assembly via interaction with HCV proteins and lipid droplets and by binding to receptors, alphaVbeta3 and CD44.
    J Virol. 2018 Apr 18. pii: JVI.02116-17. doi: 10.1128/JVI.02116.
    PubMed     Text format     Abstract available


  39. TANAKA T, Otoguro T, Yamashita A, Kasai H, et al
    Roles of the 5' Untranslated Region of Nonprimate Hepacivirus in Translation Initiation and Viral Replication.
    J Virol. 2018;92.
    PubMed     Text format     Abstract available


    March 2018
  40. AUNINS TR, Marsh KA, Subramanya G, Uprichard SL, et al
    Intracellular hepatitis C modeling predicts infection dynamics and viral protein mechanisms.
    J Virol. 2018 Mar 21. pii: JVI.02098-17. doi: 10.1128/JVI.02098.
    PubMed     Text format     Abstract available


  41. NGUYEN TT, Park EM, Lim YS, Hwang SB, et al
    Nonstructural 5A impairs DNA damage repair: Implication of hepatitis C virus-mediated hepatocarcinogenesis.
    J Virol. 2018 Mar 21. pii: JVI.00178-18. doi: 10.1128/JVI.00178.
    PubMed     Text format     Abstract available


  42. LAW JLM, Logan M, Wong J, Kundu J, et al
    Role of the E2 hypervariable region (HVR1) in the immunogenicity of a recombinant HCV vaccine.
    J Virol. 2018 Mar 14. pii: JVI.02141-17. doi: 10.1128/JVI.02141.
    PubMed     Text format     Abstract available


    February 2018
  43. RIVA L, Song OR, Prentoe J, Helle F, et al
    IDENTIFICATION OF PIPERAZINYLBENZENESULFONAMIDES AS NEW INHIBITORS OF CLAUDIN-1 TRAFFICKING AND HEPATITIS C VIRUS ENTRY.
    J Virol. 2018 Feb 28. pii: JVI.01982-17. doi: 10.1128/JVI.01982.
    PubMed     Text format     Abstract available


  44. GU J, Hardy J, Boo I, Vietheer P, et al
    Escape of Hepatitis C virus from epitope I neutralization increases sensitivity of other neutralization epitopes.
    J Virol. 2018 Feb 21. pii: JVI.02066-17. doi: 10.1128/JVI.02066.
    PubMed     Text format     Abstract available


  45. MOUSTAFA S, Karakasiliotis I, Mavromara P
    Hepatitis C virus core+1/ARFP modulates Cyclin D1/pRb pathway and promotes carcinogenesis.
    J Virol. 2018 Feb 14. pii: JVI.02036-17. doi: 10.1128/JVI.02036.
    PubMed     Text format     Abstract available


  46. SHIMIZU Y, Shirasago Y, Kondoh M, Suzuki T, et al
    Monoclonal antibodies against occludin completely prevented hepatitis C virus infection in a mouse model.
    J Virol. 2018 Feb 7. pii: JVI.02258-17. doi: 10.1128/JVI.02258.
    PubMed     Text format     Abstract available


  47. WIJESUNDARA DK, Gummow J, Li Y, Yu W, et al
    Induction of genotype-cross reactive, hepatitis C virus-specific cell mediated immunity in DNA-vaccinated mice.
    J Virol. 2018 Feb 7. pii: JVI.02133-17. doi: 10.1128/JVI.02133.
    PubMed     Text format     Abstract available


    January 2018
  48. LI Q, Tong Y, Xu Y, Niu J, et al
    Genetic Analysis of Serum-derived HCV Defective Genomes Revealed Novel Viral Cis-Elements for Virus Replication and Assembly.
    J Virol. 2018 Jan 24. pii: JVI.02182-17. doi: 10.1128/JVI.02182.
    PubMed     Text format     Abstract available


  49. YI G, Wen Y, Shu C, Han Q, et al
    Correction for Yi et al., "Hepatitis C Virus NS4B Can Suppress STING Accumulation To Evade Innate Immune Responses".
    J Virol. 2018;92.
    PubMed     Text format    


  50. TAMURA T, Fukuhara T, Uchida T, Ono C, et al
    Characterization of Recombinant Flaviviridae Viruses Possessing a Small Reporter Tag.
    J Virol. 2018;92.
    PubMed     Text format     Abstract available


  51. DUAN X, Li S, Holmes JA, Tu Z, et al
    MicroRNA-130a regulates both HCV and HBV replication through a central metabolic pathway.
    J Virol. 2018 Jan 10. pii: JVI.02009-17. doi: 10.1128/JVI.02009.
    PubMed     Text format     Abstract available


  52. KACHKO A, Costafreda MI, Zubkova I, Jacques J, et al
    Determinants in the IgV Domain of human HAVCR1 (TIM-1) are required to enhance Hepatitis C Virus Entry.
    J Virol. 2018 Jan 10. pii: JVI.01742-17. doi: 10.1128/JVI.01742.
    PubMed     Text format     Abstract available


    December 2017
  53. YANG Z, Wang X, Chi X, Zhao F, et al
    Correction for Yang et al., "Neglected but Important Role of Apolipoprotein E Exchange in Hepatitis C Virus Infection".
    J Virol. 2017;91.
    PubMed     Text format    


  54. KIM H, Bose SK, Meyer K, Ray R, et al
    Correction for Kim et al., "Hepatitis C Virus Impairs Natural Killer Cell-Mediated Augmentation of Complement Synthesis".
    J Virol. 2017;91.
    PubMed     Text format    


  55. DIXIT U, Pandey AK, Liu Z, Kumar S, et al
    Correction for Dixit et al., "FUSE Binding Protein 1 Facilitates Persistent Hepatitis C Virus Replication in Hepatoma Cells by Regulating Tumor Suppressor p53".
    J Virol. 2017;91.
    PubMed     Text format    


    November 2017
  56. PAUL D, Madan V, Ramirez O, Bencun M, et al
    Glycine-zipper motifs in hepatitis C virus nonstructural protein 4B are required for the establishment of viral replication organelles.
    J Virol. 2017 Nov 22. pii: JVI.01890-17. doi: 10.1128/JVI.01890.
    PubMed     Text format     Abstract available


  57. SKARDASI G, Chen AY, Michalak TI
    Authentic Patient-Derived Hepatitis C Virus Infects and Productively Replicates in Primary CD4+ and CD8+ T Lymphocytes In Vitro.
    J Virol. 2017 Nov 22. pii: JVI.01790-17. doi: 10.1128/JVI.01790.
    PubMed     Text format     Abstract available


  58. SCHWEITZER CJ, Zhang F, Boyer A, Valdez K, et al
    N-Myc Downstream-Regulated Gene 1 Restricts Hepatitis C Virus Propagation by Regulating Lipid Droplet Biogenesis and Viral Assembly.
    J Virol. 2017 Nov 8. pii: JVI.01166-17. doi: 10.1128/JVI.01166.
    PubMed     Text format     Abstract available


  59. MORENO-CUBERO E, Subira D, Sanz-de-Villalobos E, Parra-Cid T, et al
    According to HCV infection stage, IL-7 plus 4-1BB triggering alone or combined with PD-1 blockade increases TRAF1low HCV-specific CD8+ cell reactivity.
    J Virol. 2017 Nov 1. pii: JVI.01443-17. doi: 10.1128/JVI.01443.
    PubMed     Text format     Abstract available


    October 2017
  60. ZHOU T, Ren X, Adams RL, Pyle AM, et al
    NS3 from HCV strain JFH-1 is an unusually robust helicase that is primed to bind and unwind viral RNA.
    J Virol. 2017 Oct 25. pii: JVI.01253-17. doi: 10.1128/JVI.01253.
    PubMed     Text format     Abstract available


  61. STOECK IK, Lee JY, Tabata K, Romero-Brey I, et al
    Hepatitis C virus replication depends on endosomal cholesterol homeostasis.
    J Virol. 2017 Oct 18. pii: JVI.01196-17. doi: 10.1128/JVI.01196.
    PubMed     Text format     Abstract available


    September 2017
  62. QIN Y, Xue B, Liu C, Wang X, et al
    NLRX1 mediates MAVS degradation to attenuate hepatitis C virus-induced innate immune response through PCBP2.
    J Virol. 2017 Sep 27. pii: JVI.01264-17. doi: 10.1128/JVI.01264.
    PubMed     Text format     Abstract available


  63. FAUTEUX-DANIEL S, Larouche A, Calderon V, Boulais J, et al
    Vertical transmission of hepatitis C virus: variable transmission bottleneck and evidence of mid-gestation in utero infection.
    J Virol. 2017 Sep 20. pii: JVI.01372-17. doi: 10.1128/JVI.01372.
    PubMed     Text format     Abstract available


    August 2017
  64. KWON YC, Sasaki R, Meyer K, Ray R, et al
    HEPATITIS C VIRUS CORE PROTEIN MODULATES ENDOGLIN (CD105) SIGNALING PATHWAY FOR LIVER PATHOGENESIS.
    J Virol. 2017 Aug 9. pii: JVI.01235-17. doi: 10.1128/JVI.01235.
    PubMed     Text format     Abstract available


  65. PIERCE BG, Boucher EN, Piepenbrink KH, Ejemel M, et al
    Structure-Based Design of Hepatitis C Virus Vaccines that Elicit Neutralizing Antibody Responses to a Conserved Epitope.
    J Virol. 2017 Aug 9. pii: JVI.01032-17. doi: 10.1128/JVI.01032.
    PubMed     Text format     Abstract available


    July 2017
  66. KIM JY, Wang L, Lee J, Ou JJ, et al
    HCV induces the localization of lipid rafts to autophagosomes for its RNA replication.
    J Virol. 2017 Jul 26. pii: JVI.00541-17. doi: 10.1128/JVI.00541.
    PubMed     Text format     Abstract available


  67. YIN P, Li Y, Zhang L
    Sec24C-Dependent Transport of Claudin-1 Regulates Hepatitis C Virus Entry.
    J Virol. 2017 Jul 5. pii: JVI.00629-17. doi: 10.1128/JVI.00629.
    PubMed     Text format     Abstract available


    June 2017
  68. WELLER R, Hueging K, Brown RJP, Todt D, et al
    Hepatitis C virus strain-dependent usage of apolipoprotein E modulates assembly efficiency and specific infectivity of secreted virions.
    J Virol. 2017 Jun 28. pii: JVI.00422-17. doi: 10.1128/JVI.00422.
    PubMed     Text format     Abstract available


  69. BELOUZARD S, Danneels A, Feneant L, Seron K, et al
    Entry and release of hepatitis C virus in polarized human hepatocytes.
    J Virol. 2017 Jun 28. pii: JVI.00478-17. doi: 10.1128/JVI.00478.
    PubMed     Text format     Abstract available


  70. CEVIK RE, Cesarec M, Da Silva Filipe A, Licastro D, et al
    Hepatitis C virus NS5A targets the nucleosome assembly protein NAP1L1 to control the innate cellular response.
    J Virol. 2017 Jun 28. pii: JVI.00880-17. doi: 10.1128/JVI.00880.
    PubMed     Text format     Abstract available


  71. GOONAWARDANE N, Gebhardt A, Bartlett C, Pichlmair A, et al
    Phosphorylation of serine 225 in hepatitis C virus NS5A regulates protein-protein interactions.
    J Virol. 2017 Jun 14. pii: JVI.00805-17. doi: 10.1128/JVI.00805.
    PubMed     Text format     Abstract available


    May 2017
  72. WONG MT, Chen SS
    Hepatitis C Virus Subverts Human Choline Kinase-alpha to Bridge PI4KIIIalpha and NS5A and Upregulates PI4KIIIalpha Activation, Thereby Promoting the Translocation of the Ternary Complex to the ER for Viral Replication.
    J Virol. 2017 May 31. pii: JVI.00355-17. doi: 10.1128/JVI.00355.
    PubMed     Text format     Abstract available


  73. LI Z, Li Y, Bi Y, Zhang H, et al
    Extracellular Interactions between Hepatitis C Virus and Secreted Apolipoprotein E.
    J Virol. 2017 May 24. pii: JVI.02227-16. doi: 10.1128/JVI.02227.
    PubMed     Text format     Abstract available


  74. SYED GH, Khan M, Yang S, Siddiqui A, et al
    Hepatitis C virus lipoviroparticles (HCV-LVP) assemble in the endoplasmic reticulum (ER) and bud off from the ER to Golgi in COPII vesicles.
    J Virol. 2017 May 17. pii: JVI.00499-17. doi: 10.1128/JVI.00499.
    PubMed     Text format     Abstract available


  75. DEVHARE PB, Sasaki R, Shrivastava S, Di Bisceglie AM, et al
    Correction for Devhare et al., "Exosome-Mediated Intercellular Communication between Hepatitis C Virus-Infected Hepatocytes and Hepatic Stellate Cells".
    J Virol. 2017;91.
    PubMed     Text format    


    April 2017
  76. FILSKOV J, Mikkelsen M, Hansen PR, Christensen JP, et al
    Broadening CD4+ and CD8+ T cell responses against hepatitis C virus by vaccination with NS3 overlapping peptide panels in cross-priming liposomes.
    J Virol. 2017 Apr 26. pii: JVI.00130-17. doi: 10.1128/JVI.00130.
    PubMed     Text format     Abstract available


  77. HSU SC, Lo CW, Pan TC, Lee KY, et al
    Serine 235 Is the Primary NS5A Hyper-Phosphorylation Site Responsible for HCV Replication.
    J Virol. 2017 Apr 26. pii: JVI.00194-17. doi: 10.1128/JVI.00194.
    PubMed     Text format     Abstract available


  78. FAN H, Qiao L, Kang KD, Fan J, et al
    Attachment and Post-Attachment Receptors Important for Hepatitis C Virus Infection and Cell-to-Cell Transmission.
    J Virol. 2017 Apr 12. pii: JVI.00280-17. doi: 10.1128/JVI.00280.
    PubMed     Text format     Abstract available


    March 2017
  79. MORENO E, Gallego I, Gregori J, Lucia-Sanz A, et al
    Internal disequilibria and phenotypic diversification during replication of hepatitis C virus in a non-coevolving cellular environment.
    J Virol. 2017 Mar 8. pii: JVI.02505-16. doi: 10.1128/JVI.02505.
    PubMed     Text format     Abstract available


  80. OJIRO K, Qu X, Cho H, Park JJ, et al
    Modulation of HCV-specific CD8 effector T-cell function with antiviral effect in infectious hepatitis C virus co-culture model.
    J Virol. 2017 Mar 8. pii: JVI.02129-16. doi: 10.1128/JVI.02129.
    PubMed     Text format     Abstract available


    February 2017
  81. BALASIDDAIAH A, Davanian H, Aleman S, Pasetto A, et al
    Hepatitis C Virus-Specific T Cell Receptor mRNA-engineered Human T Cells: Impact of Antigen-Specificity on Functional Properties.
    J Virol. 2017 Feb 22. pii: JVI.00010-17. doi: 10.1128/JVI.00010.
    PubMed     Text format     Abstract available


  82. HADDAD J, Rouille Y, Hanoulle X, Descamps V, et al
    Identification of novel functions for hepatitis C virus envelope glycoprotein E1 in virus entry and assembly.
    J Virol. 2017 Feb 8. pii: JVI.00048-17. doi: 10.1128/JVI.00048.
    PubMed     Text format     Abstract available


  83. FREEDMAN H, Logan MR, Hockman D, Leman JK, et al
    Computational prediction of the heterodimeric and higher order structure of gpE1/gpE2 envelope glycoproteins encoded by the hepatitis C virus (HCV).
    J Virol. 2017 Feb 1. pii: JVI.02309-16. doi: 10.1128/JVI.02309.
    PubMed     Text format     Abstract available


    January 2017
  84. TONG Y, Chi X, Yang W, Zhong J, et al
    Functional analysis of HCV envelope protein E1 using a trans-complementation system reveals a dual role of a putative fusion peptide of E1 in both HCV entry and morphogenesis.
    J Virol. 2017 Jan 18. pii: JVI.02468-16. doi: 10.1128/JVI.02468.
    PubMed     Text format     Abstract available


  85. DEVHARE PB, Sasaki R, Shrivastava S, Di Bisceglie AM, et al
    Exosome mediated intercellular communication between hepatitis C virus infected hepatocytes and hepatic stellate cells.
    J Virol. 2017 Jan 11. pii: JVI.02225-16. doi: 10.1128/JVI.02225.
    PubMed     Text format     Abstract available


  86. HO CK, Raghwani J, Koekkoek S, Liang RH, et al
    Characterization of HCV envelope diversification from acute to chronic infection using SMRT sequencing within a sexually-transmitted hepatitis C virus cluster.
    J Virol. 2017 Jan 11. pii: JVI.02262-16. doi: 10.1128/JVI.02262.
    PubMed     Text format     Abstract available


  87. YAN Y, He Y, Boson B, Wang X, et al
    A point mutation in the N-terminal amphiphathic helix alpha0 in NS3 promotes HCV assembly by altering core localization to ER and facilitating virus budding.
    J Virol. 2017 Jan 4. pii: JVI.02399-16. doi: 10.1128/JVI.02399.
    PubMed     Text format     Abstract available


  88. WALTER S, Rasche A, Moreira-Soto A, Pfaender S, et al
    Differential Infection Patterns and Recent Evolutionary Origins of Equine Hepaciviruses in Donkeys.
    J Virol. 2016;91.
    PubMed     Text format     Abstract available


    December 2016
  89. MCCAFFREY K, Boo I, Owczarek CM, Hardy MP, et al
    An optimized hepatitis C virus E2 glycoprotein core adopts a functional homodimer that efficiently blocks virus entry.
    J Virol. 2016 Dec 28. pii: JVI.01668-16. doi: 10.1128/JVI.01668.
    PubMed     Text format     Abstract available


  90. DING Q, von Schaewen M, Hrebikova G, Heller B, et al
    Mice expressing minimally humanized CD81 and occludin genes support hepatitis C virus uptake in vivo.
    J Virol. 2016 Dec 7. pii: JVI.01799.
    PubMed     Text format     Abstract available


  91. MURAYAMA A, Sugiyama N, Suzuki R, Moriyama M, et al
    Amino Acid Mutations in the NS4A Region of Hepatitis C Virus Contribute to Viral Replication and Infectious Virus Production.
    J Virol. 2016 Dec 7. pii: JVI.02124.
    PubMed     Text format     Abstract available


    November 2016
  92. PHAM TM, Tran SC, Lim YS, Hwang SB, et al
    Hepatitis C Virus-Induced Rab32 Aggregation and its Implication in Virion Assembly.
    J Virol. 2016 Nov 16. pii: JVI.01662.
    PubMed     Text format     Abstract available


  93. ZHAO F, Zhao T, Deng L, Lv D, et al
    Visualizing the essential role of complete virion assembly machinery in efficient hepatitis C virus cell-to-cell transmission by viral infection activated split-intein mediated reporter system (VISI).
    J Virol. 2016 Nov 16. pii: JVI.01720.
    PubMed     Text format     Abstract available


  94. PIETSCHMANN T
    Clinically approved ion channel inhibitors close gates for hepatitis C virus -and open doors for drug repurposing in viral infectious diseases.
    J Virol. 2016 Nov 2. pii: JVI.01914.
    PubMed     Text format     Abstract available


  95. WANG J, Qiao L, Hou Z, Luo G, et al
    TIM-1 promotes hepatitis C virus cell attachment and infection.
    J Virol. 2016 Nov 2. pii: JVI.01583.
    PubMed     Text format     Abstract available


    October 2016
  96. LOGAN M, Law J, Wong JA, Hockman D, et al
    Native folding of a recombinant gpE1/gpE2 heterodimer vaccine antigen from a precursor protein fused with Fc IgG.
    J Virol. 2016 Oct 19. pii: JVI.01552.
    PubMed     Text format     Abstract available


  97. ELGNER F, Ren H, Medvedev R, Ploen D, et al
    The intra-cellular cholesterol transport inhibitor U18666A inhibits the exosome-dependent release of mature hepatitis C virus.
    J Virol. 2016 Oct 5. pii: JVI.01053.
    PubMed     Text format     Abstract available


    September 2016
  98. CHAN ST, Lee J, Narula M, Ou JJ, et al
    Suppression of Host Innate Immune Response by Hepatitis C Virus via the Induction of Autophagic Degradation of TRAF6.
    J Virol. 2016 Sep 28. pii: JVI.01365.
    PubMed     Text format     Abstract available


  99. BAYER K, Banning C, Bruss V, Wiltzer-Bach L, et al
    Hepatitis C virus is released via a non-canonical secretory route.
    J Virol. 2016 Sep 14. pii: JVI.01615.
    PubMed     Text format     Abstract available


  100. LI D, von Schaewen M, Wang X, Tao W, et al
    Altered glycosylation patterns increase immunogenicity of a subunit HCV vaccine inducing neutralizing antibodies which confer protection in mice.
    J Virol. 2016 Sep 14. pii: JVI.01462.
    PubMed     Text format     Abstract available


  101. ZUIANI A, Chen K, Schwarz MC, White JP, et al
    An E2 gene infectious HCV library reveals growth adaptive mutations that modulate interactions with the scavenger receptor class B type I.
    J Virol. 2016 Sep 14. pii: JVI.01011.
    PubMed     Text format     Abstract available


    June 2016
  102. MACPARLAND SA, Ma XZ, Chen L, Khattar R, et al
    Lipopolysaccharide and Tumor Necrosis Factor Alpha Inhibit Interferon Signaling in Hepatocytes by Increasing Ubiquitin-Like Protease 18 (USP18) Expression.
    J Virol. 2016;90:5549-60.
    PubMed     Text format     Abstract available


    May 2016
  103. WALTER S, Bollenbach A, Doerrbecker J, Pfaender S, et al
    Ion Channel Function and Cross-Species Determinants in Viral Assembly of Nonprimate Hepacivirus p7.
    J Virol. 2016;90:5075-89.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: